Summary
Researchers highlight curcumin, a bioactive polyphenol from <i>Curcuma longa</i>, as a promising agent in the control of chronic diseases. This compound acts on various inflammatory pathways, reducing enzymes such as COX-2 and LOX, in addition to blocking the NF-κB pathway, which is central to the inflammatory response. Curcumin also modulates the gut microbiota and has antioxidant activity, combating oxidative stress, a key mediator of inflammation. Chronic inflammatory conditions, such as rheumatoid arthritis and inflammatory bowel diseases, may benefit from its effects. However, the low bioavailability of curcumin remains a challenge, leading to the need for new formulations and clinical studies to optimize its use. The authors Maqsood et al. emphasize the importance of further research to explore synergies with other treatments and improve curcumin delivery.
Key points
- Curcuma longa (turmeric) contains curcumin, which reduces the activity of inflammatory enzymes such as COX-2 and LOX.
- Curcumin blocks the NF-κB pathway, fundamental in the inflammatory response.
- Curcumin modulates the gut microbiota, which may impact overall health and inflammation.
- Despite its benefits, curcumin's bioavailability is low, requiring new formulation approaches.
- Curcumin has therapeutic potential in conditions such as rheumatoid arthritis and cardiovascular diseases.
✦ For you
Consider including turmeric in your daily diet, whether in dishes or as tea, to take advantage of its anti-inflammatory properties. Observe how your body reacts to this addition and whether you notice any improvement in inflammation symptoms. If symptoms persist, seek a qualified healthcare professional.
For practitionersExpand
Evaluate the inclusion of curcumin in protocols for patients with chronic inflammatory diseases, considering its anti-inflammatory and antioxidant action. Be mindful of bioavailability and explore formulations that may increase absorption. Combining with other therapies may potentiate the effects of curcumin.